David Plouffe
CIK: 0001844229
Associated companies
Transaction History
| OSCR | ▲ Buy | Grant | 8,475 | $0 | 6/4/2026 | View on chart |
| OSCR | ▲ Buy | Grant | 14,134 | $0 | 6/4/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 8,974 | $0 | 6/6/2024 | View on chart |
| OSCR | ▲ Buy | Grant | 19,751 | $0 | 6/8/2023 | View on chart |
| OSCR | ▲ Buy | Grant | 35,787 | $0 | 6/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.